Six Lawsuits in Four States Accuse Xarelto Manufacturer, Distributor of Failure to Warn
At least six federal and state lawsuits have been filed in the U.S. this year claiming that four deaths as well as other serious injuries have been caused by the blood-thinning drug, Xarelto. The legal actions have been filed in Pennsylvania, Florida, Vermont and New York against Bayer, the German manufacturer of Xarelto, and its U.S. distributor, Janssen Pharmaceuticals, a Johnson & Johnson subsidiary.
All of the petitions accuse Bayer and Janssen of failing to warn the public that using Xarelto could result in irreversible internal bleeding, since the drug has no known reversal agent for its anticoagulation effect. The drug has been marketed as a preferred choice over warfarin (Coumadin), an anticoagulant that has been used in the U.S. since 1954. Warfarin’s anticoagulation is quickly reversible by administering Vitamin K.
Here are a few details about the six Xarelto lawsuits, which are likely the forerunners of many more to come.
• Virginia Stunteneck, Eastern District of Pennsylvania: Virginia Stunteneck of Kentucky began taking Xarelto in July 2012. She was prescribed the drug because of atrial fibrillation, which increases the chances of a blood clot. In February 2013, Stunteneck experienced severe gastrointestinal bleeding, which required hospitalization.
• Della Wise, on behalf of Mattie Edgin, Court of Common Pleas, Philadelphia: Della Wise filed a state lawsuit in May on behalf of her aunt, Mattie Edgin, who died while taking Xarelto.Wise’s petition accuses the defendants of fraud, wrongful death, consumer law violations, negligence, failure to warn, product liability, unreasonable marketing of a dangerous drug, and breach of warranty.
• Nancy Packard, on behalf of William Packard, Jr., Southern District of Florida: The widow of William N. Packard, Jr., who died of uncontrollable bleeding, filed a federal Xarelto lawsuit in June. William Packard began taking Xarelto in January 2012 for the treatment of atrial fibrillation. In June the same year, he developed a brain hemorrhage and was hospitalized, but doctors were unable to stop the bleeding and Packard died.
• Ruth McGowan, on behalf of Thomas Dunkley, District of Vermont: Ruth McGowan filed a wrongful death suit in July on behalf of her deceased father, Thomas Dunkley of Vermont. Dunkley took Xarelto for just 10 days in the summer of 2012, when he began bleeding in the brain, which caused a hemorrhagic stroke that led to his death.
• Jeanne Jeffcoat, Eastern District of New York: Jeanne Jeffcoat, 71, of Texas filed her federal lawsuit in July. Jeffcoat was prescribed Xarelto to reduce her likelihood of having a stroke. She took the drug from March to July 2012, when she experienced a life-threatening bleeding event that required several weeks of hospitalization and left her permanently injured.
• Harry and Joseph Griggs, on behalf of Charles Griggs, Eastern District of New York: The sons of Charles Griggs of Tennessee, who died at age 92 from severe bleeding, have filed a wrongful death lawsuit. Griggs used Xarelto from May to August 2013, when he experienced severe bleeding. The bleeding caused severe and permanent injuries, resulting in his death in December 2013. The suit accuses the defendants of “callous, reckless, willful, depraved indifference to health, safety, and welfare of the plaintiff-decedent.”
For Information, Consultation
For more information about Xarelto and your legal rights if you or a loved one have experienced adverse effects after taking Xarelto, see our webpage: “Blood Thinner Xarelto Draws Lawsuits.”
For a free consultation with an attorney about possible compensation for the harms and damages you or a loved one have experienced due to taking Xarelto, contact Hasbrook & Hasbrook by telephone (866-416-4737), email (firstname.lastname@example.org) or by using our website contact form: Contact Us.